The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.

Ecotropic viral integration site-1 (EVI1) is one of the candidate oncogenes for human acute myeloid leukemia (AML) with chromosomal alterations at 3q26. High EVI1 expression (EVI1(high)) is a risk factor for AML with poor outcome. Using DNA microarray analysis, we previously identified that integrin...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Norio Yamakawa, Kazuko Kaneda, Yusuke Saito, Emi Ichihara, Kazuhiro Morishita
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2012
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/a2f90864bbf54dcfa024ff6935b273d8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a2f90864bbf54dcfa024ff6935b273d8
record_format	dspace
spelling	oai:doaj.org-article:a2f90864bbf54dcfa024ff6935b273d82021-11-18T07:29:20ZThe increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.1932-620310.1371/journal.pone.0030706https://doaj.org/article/a2f90864bbf54dcfa024ff6935b273d82012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22295105/?tool=EBIhttps://doaj.org/toc/1932-6203Ecotropic viral integration site-1 (EVI1) is one of the candidate oncogenes for human acute myeloid leukemia (AML) with chromosomal alterations at 3q26. High EVI1 expression (EVI1(high)) is a risk factor for AML with poor outcome. Using DNA microarray analysis, we previously identified that integrin α6 (ITGA6) was upregulated over 10-fold in EVI1(high) leukemia cells. In this study, we determined whether the increased expression of ITGA6 is associated with drug-resistance and increased cell adhesion, resulting in poor prognosis. To this end, we first confirmed the expression pattern of a series of integrin genes using semi-quantitative PCR and fluorescence-activated cell sorter (FACS) analysis and determined the cell adhesion ability in EVI1(high) leukemia cells. We found that the adhesion ability of EVI1(high) leukemia cells to laminin increased with the increased expression of ITGA6 and integrin β4 (ITGB4). The introduction of small-hairpin RNA against EVI1 (shEVI1) into EVI1(high) leukemia cells reduced the cell adhesion ability and downregulated the expression of ITGA6 and ITGB4. In addition, the overexpression of EVI1 in EVI1(low) leukemia cells enhanced their cell adhesion ability and increased the expression of ITGA6 and ITGB4. In a subsequent experiment, the introduction of shRNA against ITGA6 or ITGB4 into EVI1(high) AML cells downregulated their cell adhesion ability; however, the EVI1(high) AML cells transfected with shRNA against ITGA6 could not be maintained in culture. Moreover, treating EVI1(high) leukemia cells with neutralizing antibodies against ITGA6 or ITGB4 resulted in an enhanced responsiveness to anti-cancer drugs and a reduction of their cell adhesion ability. The expression of ITGA6 is significantly elevated in cells from relapsed and EVI1(high) AML cases; therefore, ITGA6 might represent an important therapeutic target for both refractory and EVI1(high) AML.Norio YamakawaKazuko KanedaYusuke SaitoEmi IchiharaKazuhiro MorishitaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 1, p e30706 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Norio Yamakawa Kazuko Kaneda Yusuke Saito Emi Ichihara Kazuhiro Morishita The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
description	Ecotropic viral integration site-1 (EVI1) is one of the candidate oncogenes for human acute myeloid leukemia (AML) with chromosomal alterations at 3q26. High EVI1 expression (EVI1(high)) is a risk factor for AML with poor outcome. Using DNA microarray analysis, we previously identified that integrin α6 (ITGA6) was upregulated over 10-fold in EVI1(high) leukemia cells. In this study, we determined whether the increased expression of ITGA6 is associated with drug-resistance and increased cell adhesion, resulting in poor prognosis. To this end, we first confirmed the expression pattern of a series of integrin genes using semi-quantitative PCR and fluorescence-activated cell sorter (FACS) analysis and determined the cell adhesion ability in EVI1(high) leukemia cells. We found that the adhesion ability of EVI1(high) leukemia cells to laminin increased with the increased expression of ITGA6 and integrin β4 (ITGB4). The introduction of small-hairpin RNA against EVI1 (shEVI1) into EVI1(high) leukemia cells reduced the cell adhesion ability and downregulated the expression of ITGA6 and ITGB4. In addition, the overexpression of EVI1 in EVI1(low) leukemia cells enhanced their cell adhesion ability and increased the expression of ITGA6 and ITGB4. In a subsequent experiment, the introduction of shRNA against ITGA6 or ITGB4 into EVI1(high) AML cells downregulated their cell adhesion ability; however, the EVI1(high) AML cells transfected with shRNA against ITGA6 could not be maintained in culture. Moreover, treating EVI1(high) leukemia cells with neutralizing antibodies against ITGA6 or ITGB4 resulted in an enhanced responsiveness to anti-cancer drugs and a reduction of their cell adhesion ability. The expression of ITGA6 is significantly elevated in cells from relapsed and EVI1(high) AML cases; therefore, ITGA6 might represent an important therapeutic target for both refractory and EVI1(high) AML.
format	article
author	Norio Yamakawa Kazuko Kaneda Yusuke Saito Emi Ichihara Kazuhiro Morishita
author_facet	Norio Yamakawa Kazuko Kaneda Yusuke Saito Emi Ichihara Kazuhiro Morishita
author_sort	Norio Yamakawa
title	The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
title_short	The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
title_full	The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
title_fullStr	The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
title_full_unstemmed	The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
title_sort	increased expression of integrin α6 (itga6) enhances drug resistance in evi1(high) leukemia.
publisher	Public Library of Science (PLoS)
publishDate	2012
url	https://doaj.org/article/a2f90864bbf54dcfa024ff6935b273d8
work_keys_str_mv	AT norioyamakawa theincreasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT kazukokaneda theincreasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT yusukesaito theincreasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT emiichihara theincreasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT kazuhiromorishita theincreasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT norioyamakawa increasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT kazukokaneda increasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT yusukesaito increasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT emiichihara increasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia AT kazuhiromorishita increasedexpressionofintegrina6itga6enhancesdrugresistanceinevi1highleukemia
_version_	1718423366083280896

The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.

Ejemplares similares